AilsynBio Limited is an AI-driven biotech company dedicated to developing next-generation orally available cyclic peptide therapeutics. Our proprietary AI platform integrates advanced molecular modeling, medicinal chemistry, and biology to design and rapidly optimize cyclic peptides against challenging